Impact Factor 2024: 1.7
Current issue – 09/2025
Imaging of the postoperative spine
Simranjeet Kaur, Radhesh Lalam, Rishi Trivedi
There has been a significant increase in the number of spinal surgical procedures performed over the last few decades, resulting in a proportionate increase in the number of postoperative imaging studies. S. Kaur et al. performed an exhaustive literature search along with consideration of various guidelines and expert opinions regarding postoperative spine imaging. Their review discusses the normal postoperative appearance and the various early and delayed complications.
Amir Karimzadeh, Wencke Lehnert, Daniel Koehler et al.
Theranostics in nuclear oncology combines diagnostic and therapeutic procedures using radiotracers to target tumor cells. Prostate-specific membrane antigen (PSMA) is a key target in metastatic prostate cancer, and the radioligand [177Lu]Lu-PSMA-617, which binds to PSMA, has shown promising results in treating metastatic castration-resistant prostate cancer (mCRPC). In this review A. Karimzadeh and colleagues discuss the current evidence of [177Lu]Lu-PSMA-617 in mCRPC in the context of selected studies and the joint EANM/SNMMI guidelines for Lutetium-177-labeled PSMA-targeted radioligand therapy.
Standardized Reporting of HCC with LI-RADS and mRECIST: Update on the Situation in Germany
Christian Nelles, Inka Ristow, Markus S. Juchems et al.
C. Nelles et al. performed an online survey about the current status of CT protocols in hepatocellular carcinoma (HCC) in the year 2023/2024. Moreover, the usage of structured reporting using LI-RADS and mRECIST was surveyed and the results were compared with a survey from 2020.
